A novel 4-(1,3,4-thiadiazole-2-ylthio)pyrimidine derivative inhibits cell proliferation by suppressing the MEK/ERK signaling pathway in colorectal cancer
Colorectal cancer (CRC) is one of the most common types of malignant cancers worldwide. Although molecularly targeted therapies have significantly improved treatment outcomes, most of these target inhibitors are resistant. Novel inhibitors as potential anticancer drug candidates are still needed to...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Sciendo
2023-09-01
|
| Serie: | Acta Pharmaceutica |
| Soggetti: | |
| Accesso online: | https://doi.org/10.2478/acph-2023-0025 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|